AAD secures BARDA contract for early sepsis detection test

2019 07 15 17 19 4107 Bacteria Blood Sepsis 400

Rapid diagnostic and data system firm Advanced Animal Diagnostics (AAD) has secured a contract with the Biomedical Advanced Research and Development Authority's (BARDA) Division of Research, Innovation and Ventures for the development of a test for early detection of severe infection.

QScout RLD+ can be used in urgent care clinics, doctor's offices, and other nonhospital settings, the company said. It is a rapid hematology analyzer that can describe a seven-part leukocyte differential, including quantifying band neutrophils and other immature granulocytes which can indicate severe infection. Results are available in two minutes compared to the two hours often required by a hospital's testing protocol, according to AAD.

BARDA is part of the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response.

Page 1 of 31
Next Page